Showing results (21-30 of 41) with videos related to
Sort By:
Pageof 5
Clinical Physiology and Functional Imaging|April 12, 2021
Per-rectal portal scintigraphy as an alternative measure of hepatic venous pressure gradient in chronic liver disease: A preliminary reportKohei Kotani, Sawako Uchida-Kobayashi, Akira Yamamoto, et al.Clinical Journal of Gastroenterology|February 4, 2023
A case of hepatocellular carcinoma with "pseudoprogression" followed by complete response to atezolizumab plus bevacizumabNaoshi Odagiri, Akihiro Tamori, Kohei Kotani, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 7, 2024
Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapyRitsuzo Kozuka, Masaru Enomoto, Yoshimi Yukawa-Muto, et al.European Radiology|September 22, 2025
Deep-learning-based prediction of significant portal hypertension with single cross-sectional non-enhanced CTAkira Yamamoto, Shingo Sato, Daiju Ueda, et al.JGH Open : an Open Access Journal of Gastroenterology and Hepatology|October 26, 2020
High dropout rate from aftercare program of antihepatitis C therapy for patients with history of injection drug useAkihiro Tamori, Sawako Uchida-Kobayashi, Ritsuzo Kozuka, et al.Cancers|February 27, 2026
12-Hydroxyheptadecatrienoic Acid Predicts Hepatocellular Carcinoma Development During Nucleos(t)ide Analogue TherapyHiroko Ikenaga, Ritsuzo Kozuka, Kirara Inoue, et al.Clinical Journal of Gastroenterology|April 26, 2019
Interstitial pneumonia suspected during regorafenib administration and exacerbated by subsequent therapy with lenvatinib for unresectable hepatocellular carcinomaKohei Kotani, Masaru Enomoto, Masako Okada, et al.Journal of Viral Hepatitis|December 30, 2022
Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohortRitsuzo Kozuka, Akihiro Tamori, Masaru Enomoto, et al.Cancers|July 30, 2020
Early Change in the Plasma Levels of Circulating Soluble Immune Checkpoint Proteins in Patients with Unresectable Hepatocellular Carcinoma Treated by Lenvatinib or Transcatheter Arterial ChemoembolizationNaoshi Odagiri, Hoang Hai, Le Thi Thanh Thuy, et al.Digestive Diseases and Sciences|March 9, 2012
Effect of mosapride citrate on gastric emptying in interferon-induced gastroparesisEtsushi Kawamura, Masaru Enomoto, Kohei Kotani, et al.Pageof 5